Patients with drug treatments were allocated into four categories as follows: with antidepressants, with antipsychotics, switching medication, and combined medication. In Group A (6-month follow-up group), 63 patients were treated with medications, with 42 of these patients with antidepressants, 5 patients with antipsychotics, 5 patients with switching medication, and 11 patients with combined medication. In Group B (12-month follow-up group), 25 patients were treated with medications, with 17 of these patients with antidepressants, 2 patients with antipsychotics, 4 patients with switching medication, and 2 patients with combined medication. The choice of antidepressants included four SSRI, i.e., fluoxetine, paroxetine, escitalopram, and sertraline, and one noradrenergic and specific serotonergic antidepressant (NaSSA), i.e., mirtazapine. There was a single choice of antipsychotic medication: sulpiride.
Free full text: Click here